AAAAAA

   
Results: 1-25 |
Results: 25

Authors: Dittmann, H Sokler, M Kollmannsberger, C Dohmen, BM Baumann, C Kopp, A Bares, R Claussen, CD Kanz, L Bokemeyer, C
Citation: H. Dittmann et al., Comparison of (18)FDG-PET with CT scans in the evaluation of patients withresidual and recurrent Hodgkin's lymphoma, ONCOL REP, 8(6), 2001, pp. 1393-1399

Authors: Kuczyk, MA Bokemeyer, C Hartmann, J Schubach, J Walter, C Machtens, S Knuchel, R Kollmannsberger, C Jonas, U Serth, J
Citation: Ma. Kuczyk et al., Predictive value of altered p27(Kip1) and p21(WAF/Cip1) protein expressionfor the clinical prognosis of patients with localized prostate cancer, ONCOL REP, 8(6), 2001, pp. 1401-1407

Authors: Kollmannsberger, C Mayer, F Kuczyk, M Kanz, L Bokemeyer, C
Citation: C. Kollmannsberger et al., Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapy, WORLD J URO, 19(2), 2001, pp. 120-125

Authors: Machtens, S Serth, J Bokemeyer, C Bathke, W Minssen, A Kollmannsberger, C Hartmann, J Knuchel, R Kondo, M Jonas, U Kuczyk, M
Citation: S. Machtens et al., Expression of the p53 and maspin protein in primary prostate cancer: Correlation with clinical features, INT J CANC, 95(5), 2001, pp. 337-342

Authors: Kollmannsberger, C Gerl, A Schleucher, N Beyer, J Kuczyk, M Rick, O Gasper, J Sosada, M Rie, C Kanz, L Bokemeyer, C
Citation: C. Kollmannsberger et al., Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancer, ANTI-CANC D, 11(7), 2000, pp. 535-539

Authors: Kollmannsberger, C Nichols, C Meisner, C Mayer, F Kanz, L Bokemeyer, C
Citation: C. Kollmannsberger et al., Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: An explorative analysis using cart modeling, ANN ONCOL, 11(9), 2000, pp. 1115-1120

Authors: Kollmannsberger, C Nichols, C Bamberg, M Hartmann, JT Schleucher, N Beyer, J Schoffski, P Derigs, G Ruther, U Bohlke, I Schmoll, HJ Kanz, L Bokemeyer, C
Citation: C. Kollmannsberger et al., First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases, ANN ONCOL, 11(5), 2000, pp. 553-559

Authors: Bokemeyer, C Kollmannsberger, C Hartmann, JT Kanz, L
Citation: C. Bokemeyer et al., Follow up after primary treatment: curable diseases treated non-surgically, ANN ONCOL, 11, 2000, pp. 73-78

Authors: Kollmannsberger, C Bokemeyer, C
Citation: C. Kollmannsberger et C. Bokemeyer, Therapy-related leukemia following high-dose chemotherapy: Compensating for the benefit?, ONKOLOGIE, 23(5), 2000, pp. 480-482

Authors: Kollmannsberger, C Quietzsch, D Haag, C Lingenfelser, T Schroeder, M Hartmann, JT Baronius, W Hempel, V Clemens, M Kanz, L Bokemeyer, C
Citation: C. Kollmannsberger et al., A phase II study of paclitaxel, weekly, 24-hour continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer, BR J CANC, 83(4), 2000, pp. 458-462

Authors: Kollmannsberger, C Kuzcyk, M Mayer, F Hartmann, JT Kanz, L Bokemeyer, C
Citation: C. Kollmannsberger et al., Late toxicity following curative treatment of testicular cancer, SEM SURG ON, 17(4), 1999, pp. 275-281

Authors: Hartmann, JT Quietzsch, D Daikeler, T Kollmannsberger, C Mayer, F Kanz, L Bokemeyer, C
Citation: Jt. Hartmann et al., Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancer, ANTI-CANC D, 10(8), 1999, pp. 729-733

Authors: Kollmannsberger, C Brugger, W Hartmann, JT Maurer, F Bohm, P Kanz, L Bokemeyer, C
Citation: C. Kollmannsberger et al., Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcoma, ANTI-CANC D, 10(5), 1999, pp. 453-456

Authors: Kollmannsberger, C Pressler, H Mayer, F Kanz, L Bokemeyer, C
Citation: C. Kollmannsberger et al., Cisplatin-refractory, HER2/neu-expressing germ-cell cancer: Induction of remission by the monoclonal antibody Trastuzumab, ANN ONCOL, 10(11), 1999, pp. 1393-1394

Authors: Bokemeyer, C Hartmann, JT Kollmannsberger, C Mayer, F Kanz, L
Citation: C. Bokemeyer et al., UFT/calcium folinate plus weekly paclitaxel for solid tumors, ONCOLOGY-NY, 13(7), 1999, pp. 106-111

Authors: Bokemeyer, C Kollmannsberger, C Meisner, C Harstrick, A Beyer, J Metzner, B Hartmann, JT Schmoll, HL Einhorn, L Kanz, L Nichols, C
Citation: C. Bokemeyer et al., First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis, J CL ONCOL, 17(11), 1999, pp. 3450-3456

Authors: Hartmann, JT Kuczyk, MA Kollmannsberger, C Kanz, L Bokemeyer, C
Citation: Jt. Hartmann et al., Future prospects in the chemotherapy of metastatic nonseminomatous testicular germ-cell cancer, WORLD J URO, 17(5), 1999, pp. 324-333

Authors: Kollmannsberger, C Mross, K Jakob, A Kanz, L Bokemeyer, C
Citation: C. Kollmannsberger et al., Topotecan - A novel topoisomerase I inhibitor: Pharmacology and clinical experience, ONCOL-BASEL, 56(1), 1999, pp. 1-12

Authors: Bokemeyer, C Kollmannsberger, C Harstrick, A Beyer, J Gerl, A Casper, J Metzner, B Hartmann, JT Schmoll, HJ Kanz, L
Citation: C. Bokemeyer et al., Treatment of patients with cisplatin-refractory testicular germ-cell cancer, INT J CANC, 83(6), 1999, pp. 848-851

Authors: Kollmannsberger, C Hartmann, JT Kanz, L Bokemeyer, C
Citation: C. Kollmannsberger et al., Therapy-related malignancies following treatment of germ cell cancer, INT J CANC, 83(6), 1999, pp. 860-863

Authors: Hartmann, JT Kollmannsberger, C Kanz, L Bokemeyer, C
Citation: Jt. Hartmann et al., Platinum organ toxicity and possible prevention in patients with testicular cancer, INT J CANC, 83(6), 1999, pp. 866-869

Authors: Hartmann, JT Albrecht, C Schmoll, HJ Kuczyk, MA Kollmannsberger, C Bokemeyer, C
Citation: Jt. Hartmann et al., Long-term effects on sexual function and fertility after treatment of testicular cancer, BR J CANC, 80(5-6), 1999, pp. 801-807

Authors: Bokemeyer, C Kollmannsberger, C
Citation: C. Bokemeyer et C. Kollmannsberger, Secondary malignancies, ANTICANCER DRUG TOXICITY, 1999, pp. 525-547

Authors: Bokemeyer, C Kollmannsberger, C Kanz, L
Citation: C. Bokemeyer et al., The potential role of topotecan in the treatment of pediatric and adult soft-tissue sarcomas, ONKOLOGIE, 21, 1998, pp. 32-36

Authors: Jakob, A Kollmannsberger, C Kanz, L Bokemeyer, C
Citation: A. Jakob et al., Late toxicity after treatment for testicular germ cell cancer, UROLOGE, 37(6), 1998, pp. 635-647
Risultati: 1-25 |